The primary obstacle in nanomedicine is not the potency of the drug, but the body’s own defense systems. When synthetic nanoparticles enter the bloodstream, the mononuclear phagocyte system (MPS)—the body’s "trash collection" service—quickly identifies them as foreign and sequesters them in the liver or spleen. This leads to poor circulation times and off-target toxicity.
To solve this, researchers are turning to a "Trojan Horse" strategy: cell membrane camouflage. By wrapping synthetic cores in natural cell membranes, scientists can inherit the biological complexity of a living cell, allowing therapeutic agents to hide in plain sight and navigate the body using nature's own GPS.
The Stealth Mechanism: Bypassing the Immune System
The most immediate benefit of membrane coating is immune evasion. Natural cells, such as erythrocytes (red blood cells), have evolved to circulate for months without being attacked. They achieve this through a "don't eat me" signal, primarily the protein CD47, which tells macrophages to stand down.
By harvesting these membranes and fusing them onto nanoparticles, researchers like Guihong Lu and Feng Li have shown that synthetic materials can achieve a two-order-of-magnitude increase in stability (Antimonene with two-orders-of-magnitude improved stability for high-performance cancer theranostics). This isn't just about physical protection; it’s about biological mimicry. As Yunxuan Feng demonstrated, even recruiting endogenous proteins like albumin can mask a delivery vehicle, preventing it from being recognized by receptors that drive liver sequestration (Albumin-recruiting lipid nanoparticle potentiates the safety and efficacy of mRNA vaccines by avoiding liver accumulation).
Targeted Homing: Leveraging Natural Affinities
Beyond stealth, different cell membranes provide specialized "homing" capabilities based on their source:
- Homotypic Targeting: Cancer cell membranes possess unique surface adhesion molecules that naturally recognize and bind to other cells of the same type. Xiaodong Zhuang utilized this "self-recognition" to deliver chemotherapy specifically to leukemia cells, significantly increasing drug accumulation at the tumor site (Artificial cell vesicle-mediated delivery of Catharanthus roseus (L.) G. Don-derived vinca alkaloids for enhanced antitumor efficacy).
- Vascular Injury Homing: Platelets are naturally programmed to stick to damaged blood vessels and inflammatory sites. Tianyi Wang and colleagues used platelet-camouflaged nanoparticles to deliver miRNA inhibitors directly to injured heart tissue, bypassing the liver and focusing the treatment where it was needed most (Platelet membrane-camouflaged nanoparticles carry microRNA inhibitor against myocardial ischaemia‒reperfusion injury).
- Inflammatory Tropism: Macrophages and neutrophils are recruited to sites of inflammation and tumors. By using macrophage-derived vesicles, Xiaojun Wang showed that these "biomimetic drones" could cross the notoriously difficult blood-brain barrier (BBB) to treat glioblastoma (Exploration and functionalization of M1-macrophage extracellular vesicles for effective accumulation in glioblastoma and strong synergistic therapeutic effects).
From Passive Carriers to Active Cyborgs
The field is moving beyond simple coatings toward "cyborg" systems where the cell itself performs a therapeutic function. Xiangli Ru developed a method to synthesize calcium carbonate nanodots inside living red blood cells. These "cyborg erythrocytes" act as mobile scrubbers, entering the bloodstream to selectively remove toxic lead ions while maintaining their natural oxygen-carrying capacity (Synthesis of calcium carbonate nanoparticles in erythrocytes enables efficient removal of extracellular lead ions).
Similarly, researchers are exploring hybrid membranes—fusing the properties of two different cell types, such as red blood cells for longevity and cancer cells for targeting—to create multifunctional delivery systems that neither nature nor chemistry could produce alone (Combinational Antitumor Strategies Based on the Active Ingredients of Toad Skin and Toad Venom).
Why It Works: The Interface of Biology and Engineering
The intuition behind this research direction is that complexity is easier to borrow than to build. A synthetic nanoparticle coated in PEG (polyethylene glycol) is a simple chemical solution to a complex biological problem. In contrast, a cell membrane is a dense forest of proteins, carbohydrates, and lipids that have been refined by evolution to interact perfectly with the body's signaling pathways.
By shifting the focus from designing better synthetic surfaces to harvesting biological ones, researchers like Jiechao Ge and Lijun Zhang are bridging the gap between the laboratory and the clinic, creating "all-in-one" nanotheranostics that are more biocompatible, more precise, and more effective (Recent advances and prospects of carbon dots in cancer nanotheranostics).